INTRODUCTION
In the latest edition of our series of neuroanatomical areas of importance for neuropsychiatry, Wayne 
The ventral anterior cingulate cortex (ACC) increasingly has been implicated in the modulation of emotional behavior on the basis of neuroimaging studies in humans and lesion analyses in experimental animals. In a neuroimaging study of mood disorders, 1 it was discovered that this region's gray matter volume was abnormally reduced in familial bipolar disorder and major depressive disorder (MDD). The magnetic resonance imaging-(MRI) based morphometric measures acquired to demonstrate this abnormality were guided by positron emission tomography (PET) images showing an abnormal reduction of cerebral blood flow (CBF) and glucose metabolism in the prefrontal cortex (PFC) ventral to the corpus callosum genu (ie, "subgenual") in depression ( Figure 1 ). 1 Voxel-by-voxel analyses of neurophysiological data from independent depressed samples versus controls localized the peak difference in activity more specifically to the subgenual ACC (sgACC). Because antidepressant treatment did not reverse these physiological abnormalities, MRI measures of gray matter volume of the sgACC were obtained to determine whether the decrements in regional CBF and metabolism might be accounted for by a corresponding reduction in cortex. 2 This hypothesis was confirmed, as the mean gray matter volume of the left sgACC was reduced in bipolar disorder and MDD compared with healthy control samples. 1 In pursuing the nature of these neuroimaging
The area of reduced glucose metabolism in the subgenual PFC is illustrated in images composed of voxel tvalues that compare depressives and controls, shown in sagittal (left) and coronal (right) sections 1, 2 This image was produced by a voxel-by-voxel computation of the unpaired t-statistic t-statistic t 2 to identify inherent differences in metabolism between samples of familial bipolar and unipolar depressives relative to healthy controls. 1 The t-images shown were generated to provide optimal localization of a regional t-images shown were generated to provide optimal localization of a regional t metabolic abnormality identified using other techniques, which included comparisons involving independent subject samples. 1 The negative t-values, t-values, t shown in a coronal section at 31 mm anterior to the anterior commissure (y=31 mm) and a sagittal section at 3 mm left of the midline (x=-3 mm), correspond to areas where metabolism is decreased in the depressives relative to the controls. Both the stereotaxic center-of-mass of the peak metabolic difference shown here (x=-2, y=32, z=-2; interpreted as in Table 1 ) and that of the peak blood flow difference computed in an independent subject set (x=1, y=25, z=-6) localized to the agranular region of the anterior cingulate gyrus ventral to the corpus callosum. The mean normalized metabolism for each group is shown from Drevets and colleagues. 1 However, the area of reduced metabolism in the sgACC was at least partly accounted for by a corresponding reduction in cortex in both the bipolar disordered and the unipolar depressed groups relative to the control group ( Figure 3 ). While the spatial resolution of PET precludes clear laterality distinctions in midline structures, the MRI-based neuromorphometric measures showed the grey matter volume reduction to be left-lateralized. Anterior is to the left and dorsal toward the top.
abnormalities, Ongür and colleagues 3 undertook postmortem assessments of brain tissue taken from the sgACC of subjects diagnosed as having bipolar disorder, MDD, schizophrenia, or no psychiatric disorder. The sgACC implicated by the neuroimaging data consisted of Brodmann area (BA) 24b and, to a lesser extent, BA 24a anteriorly, and area 25 posteriorly (Figure 2) . 4 Although the PET data showed that the posterior and anterior sgACC were affected, the peak difference between groups localized to the anterior sgACC. Thus, initial histopathological assessments targeted the section of BA 24 located ventral and posterior to the corpus callosum genu (Figure 3 ). These assessments confirmed the reduction in mean sgACC gray matter volume in bipolar disorder and MDD versus healthy controls, and associated this deficit with a reduction in glia and no equivalent loss of neurons. 3 The neuronal density appeared increased, as would be expected in association with a reduction in neuropil (moss-like layer of gray matter containing axons and dendrites that occupies most of the cortex volume).
SPECIFICITY OF STRUCTURAL NEUROIMAGING ABNORMALITIES IN THE SUBGENUAL ANTERIOR CINGULATE CORTEX
Other studies have shown that this volumetric reduction existed early in the illness course of MDD and bipolar disorder 5, 6 and was also evident in young adults at high familial risk for MDD 7, 8 Furthermore, this abnormality persisted during antidepressant treatment and was present in the manic and depressed phases of bipolar disorder. 1 The volumetric deficit applied to males 8, 9 and females, 5 to psychotic unipolar and bipolar depression, 6, 10, 11 and to bipolar-spectrum illness. 12 The variability of the volumetric measures of gray matter volume in the sgACC across subjects was high, the ranges of values in ill and normative groups overlapped substantially, and not all studies replicated these findings (Tables 1-4) . Such variability is typical of neurobiological data acquired from mood disordered samples, partly because MDD and bipolar disorder appear heterogenous with respect to etiology, and studies gen- Mean (±SEM) MRI-based volumes of the left sgACC gray matter differed between the bipolar disordered, unipolar depressed, and control groups 4 The left subgenual PFC/whole brain volume ratio also was reduced in the bipolar and unipolar groups relative to the control group. Although the bipolar subjects who underwent PET imaging had been unmedicated prior to scanning, additional bipolar subjects were included in the MRI portion of the study who had been chronically medicated with lithium (n=4) or divalproex (n=2). The mean volume for this medicated subsample is shown separately, and differed significantly (P<.05) from both the unmedicated P<.05) from both the unmedicated P bipolar disorder and MDD groups, but did not differ significantly from the healthy control group. 7 Research by Drevets and colleagues 13 limited the sample selection to early-onset MDD and bipolar disorder cases, who have shown volumetric abnormalities that are localized more specifically to some PFC and temporal lobe structures.
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In unipolar depressives, to further enhance the sensitivity for identifying neurobiological markers for affective illness, Drevets and colleagues 1 initially selected cases according to criteria for "familial pure depressive disease, " a condition defined by having an MDD subject with a firstdegree relative with MDD, but no first-degree relative with mania, alcoholism, or sociopathy. 21 In contrast to MDD samples with familial pure depressive disease or familial bipolar disorder, subjects who met criteria for depression spectrum disease (MDD subjects who have a first-degree relative with alcoholism or sociopathy 21 did not differ * Only the results of these studies' that pertained to the pgACC are reviewed here; many of these studies also reported neurophysiological abnormalities in other medial PFC regions that are reviewed elsewhere. 34 † Stereotaxic coordinates corresponding to the spatial array of Talairach and Tournoux 35 such that positive x=right of the midline, positive y=anterior to the anterior commissure, and positive z=dorsal to the horizontal plane containing the anterior and posterior commissures. ‡ BAs approximated from the human cytoarchitectonic maps of Ongür and colleagues. 4 In some cases, these BA designations differed from those reported in the primary articles. § The sgACC additionally showed a nonsignificant trend toward reduced blood flow in the depressives versus controls in this study. The Drevets and colleagues 14 study was performed using an earlier generation-and lower spatial resolution-PET camera than that used by Drevets and colleagues, 1 which may account for the higher sensitivity in this latter study compared with the former study for detecting differences in the relatively small sgACC. // This y-coordinate from the Drevets and colleagues 14 study was based upon the stereotaxic array of Talairach and colleagues, 35 in which the origin was the midpoint of the segment connecting the anterior and posterior commissures. In the current Table, this coordinate has been translated to the stereotaxic array of Talairach and Tournoux (1988) , in which the origin was the anterior commissure. ¶ Coordinates were obtained from a statistical parametric map computed post hoc by combining the 10 unipolar depressives with bipolar depressives scanned using the same technique. Drevets and colleagues 1 also enhanced the likelihood of identifying biological markers in bipolar disorder by selecting subjects who had first-degree relatives with bipolar disorder. The extent to which the neuroimaging abnormalities in the sgACC also extend to non-familial cases, thus, remained unclear. An MRI study from an independent laboratory 6 found that the mean sgACC gray matter volume (defined using the same anatomical landmarks we used) was reduced significantly versus controls in bipolar disorder subjects with mood disordered first-degree relatives, but not in bipolar disorder subjects without mood disordered first-degree relatives. Consistent with these data, McDonald and colleagues 42 showed that reduced volume of a right "perigenual" ACC region that included both the sgACC and the ACC situated anterior to the corpus callosum genu (ie, "pregenual"; pgACC) was associated with increasing genetic risk for bipolar disorder (based upon the numbers of affected relatives). Boes and colleagues 8 found that the left pgACC (sgACC plus pgACC) volume was smaller in boys with sub-clinical depressive symptoms, and that the negative correlation between left sgACC volume and depression symptoms was particularly robust in boys with a family history of depression.
In more recent research, morphometric MRI studies 4 divided this region into anterior and posterior sgACC regions, which corresponded approximately to BAs 24 and 25, respectively (Figure 2 ). The posterior sgACC appears homologous with the infralimbic cortex (BA 25) of the rodent and monkey on the basis of cytoarchitectonic and connectional features. 4 The posterior sgACC volume was reduced in MDD cases with psychotic features, but not in a psychiatric control group with schizophrenia. 10 Only the MDD group showed an increase in posterior sgACC gray matter after a 2-year follow-up period (of naturalistic treatment). For the MDD subjects, but not for the subjects with schizophrenia, the Global Assessment Scale scores during follow-up correlated positively with cortical depth at baseline and with volume increases during follow-up. Thus, the volumetric abnormalities in this region may predict and reflect the course of depressive illness.
The finding that the posterior sgACC volume may increase in association with prolonged clinical improvement is noteworthy based upon cross-sectional studies (Neumeister et al, unpublished data, 2008) of MDD cases studied during long-term remission. Despite the finding that the sgACC volume deficit in MDD showed no significant change during antidepressant treatment for a mean of 4 months, 36 subjects with a history of MDD who were selected for their capacity to remain in remission while unmedicated for at least 3 months (and a mean of several years) showed sgACC volumes that were significantly higher than those of controls. These cross-sectional data did not allow determination of whether such subjects had manifested reduced sgACC vol- ume during depression that then had increased during prolonged remission, or whether these subjects were instead resilient to the pathophysiologcal process that led to the reduction in sgACC volume during MDD. Longitudinal studies are needed to elucidate this issue, but the possibility that such individuals possess (a) resilience factor(s) that allows them to recover from major depressive episodes without the development of chronic illness would hold great potential clinical importance in mood disorders research.
However, chronic lithium treatment, which exerts robust neurotrophic effects in animal models, has been associated with increasing gray matter volume toward normal in treatment responders in the sgACC and other PFC areas (Figure 3) . 50 Partly compatible with these data, Bearden and colleagues 47 reported that the volumes of the left ACC, including of the sgACC, were greater in lithium-treated bipolar disorder subjects than both healthy controls and bipolar disorder subjects not receiving lithium. In magnetic resonance spectroscopy studies of bipolar disorder, chronic lithium treatment also was associated with increased concentrations of N-acetyl-aspar-N-acetyl-aspar-N tate (NAA), a marker of neuronal integrity. 52 * All of these studies were performed using 1.5T MRI scanners. Differences between groups were identified using either the more sensitive ROI approach or VBM. The image slice thickness is listed. † The ROI approach does not generate a set of stereotaxic coordinates that indicates the peak difference between groups. ‡ The ROI applied for the outcome measures in this study included the perigenual ACC, but also included the more dorsal supragenual ACC. 

ANATOMICAL SPECIFICITY OF SUBGENUAL ANTERIOR CINGULATE CORTEX ABNORMALITIES
Most neuroimaging studies have not identified significant differences between mood disordered and healthy control groups in the volumes of the whole brain, although several groups have reported gray matter loss in other portions of anterior or posterior cingulate cortex. 62 In the ACC, abnormalities in CBF/metabolism, tissue volume, and glial cells have been demonstrated in the ACC situated anterior to the corpus callosum genu (ie, pgACC). This region includes portions of BAs 24 and 32, an area that also forms an integral part of the ventral "emotion" circuit implicated in affective illness. 63 The sgACC shares similarities with the pgACC area situated immediately adjacent to the sgACC, Smaller L sgACC in BD vs both healthy and autism control groups * The magnetic field strength for the MRI scanner employed is listed for each study. Differences between groups were identified using either the more sensitive ROI approach or VBM. The image slice thickness is listed. † The ROI approach does not generate a set of stereotaxic coordinates that indicates the peak difference between groups, therefore coordinates are listed only where relevant for the studies that assessed regional grey matter using the VBM approach. ‡ The ROI applied for the outcome measures in this study included the perigenual ACC, but also included the more dorsal supragenual ACC. § Although this article aimed at defining the sgACC ROI using the same landmarks as Drevets and colleagues, 1 Botteron and colleagues, 5 and Hirayasu and colleagues, 6 the volumes obtained in the healthy control subjects in the Brambilla and colleagues 53 study were almost two-fold greater than those obtained in these other studies, suggesting that differences existed in the application of these methods in the latter relative to the former studies.
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pgACC=pregenual anterior cingulate cortex; BD=biploar disorder; HC=healthy control; ROI=region of interest; NR=not reported; L=left; sgACC=subgenual anterior cingulate cortex; SCZ=schizophrenia; AP=antipsychotics; MS=mood stabilizers; R=right; BD-I=bipolar I disorder; BD-II=bipolar II disorder; VBM=voxel-based morphometry; MTI=magnetization transfer imaging; AD=antidepressants; BA=Brodmann area; BZ=benzodiazepines; NOS=not otherwise specified; ADHD=attention-deficit/hyperactivity disorder; ODD=oppositional defiant disorder; CD=conduct disorder; CNS=central nervous system; IQ=intelligence quotient; MRI=magnetic resonance imaging. such that distinctions of the cortex at the actual sgACC/pgACC interface seem arbitrary. The anterior sgACC and the adjacent ventral pgACC both are cytoarchitectonically BA 24, and they share similar anatomical connectivity. 4 Moreover, the abnormal reductions of glia in MDD extend to the pgACC (BA 24) 64 as well as to the orbitofrontal and dorsal anterolateral PFC (BA 9) 65-67 and the amygdala. 68, 69 Hence, the term "perigenual" ACC is often applied to the ACC near the genu, and for comparison we listed findings in the pgACC together with those in the adjacent sgACC in Tables 1-4 .
NEUROPHYSIOLOGICAL IMAGING STUDIES OF SUBGENUAL ANTERIOR CINGULATE CORTEX ACTIVITY
Nevertheless, the functions of the anterior sgACC and more dorsal regions of the pgACC appear distinct with respect to some neuroimaging studies of emotional behavior. The tissue near the sgACC/pgACC junction shows increased hemodynamic activity during a variety of emotional-behavioral tasks, including tasks involving sadness induction 70, 71 ; exposure to traumatic reminders 72 ; selecting sad or happy targets in an emotional go-no-go study 73 ; monitoring of internal states in individuals with attachment avoidant personality styles 74 ; and extinction learning to previously fear-conditioned stimuli. 75 These findings suggest in humans roles the ACC in the automatic regulation of emotional behavior. In contrast, more dorsal regions of the pgACC show physiological responses to more diverse types of emotionally valenced or autonomically arousing stimuli. [76] [77] [78] In mood disorders, the sgACC activity frequently has been shown to correlate positively with the severity of depressive symptoms, 79 whereas the pgACC activity has more consistently been linked to treatment outcome. 80 The reduction in resting sgACC CBF and metabolism that we initially observed in depressed bipolar disorder and MDD subjects has been replicated by other studies of MDD 20, 26, 38 and bipolar disorder (Tables 1 and 2) . 24, [37] [38] [39] These findings also were extended by data showing that metabolic reductions predate the onset of clinical symptoms, as Kumano and colleagues 31 found that cancer patients who went on to develop depression had lower baseline metabolic rates of the sgACC compared with cancer controls who did not become depressed. However, other studies reported increased metabolic activity in the sgACC in primary 15, 16, 19, 28, 30, 41, 45, 81 or secondary depression. 82 These apparently discrepant results may be explained by the interrelationships between deficits in gray matter volume and physiological imaging data. The reduction in sgACC volume is sufficiently prominent (ranging in magnitude from 15% to 50% across positive studies [ Tables  3 and 4] ) to produce partial volume effects in functional brain images due to their relatively low spatial resolution. Therefore, although relative to controls, the depressed MDD and bipolar disorder subjects showed metabolic activity that appeared reduced in the sgACC, 1 when this volumetric deficit was taken into account by correcting the metabolic data for the partial volume averaging effect associated with the corresponding gray matter reduction, metabolism instead appeared increased in the sgACC in the unmedicated-depressed phase and normal in the medicated-remitted phase. 83 Consistent with the conclusions of these partial volume corrections, researchers consistently show that the sgACC metabolism is elevated in the depressed phase relative to the remitted phase of the same MDD subjects. For example, in studies of remitted MDD subjects, the sgACC metabolism increases during depressive relapse induced during either tryptophan depletion 84 or catecholamine depletion. 85 Moreover, the sgACC metabolism decreases during effective antidepressant treatment. For example, Drevets and colleagues, 1 Drevets and colleagues, 38 Holthoff and colleagues, 25 and Mayberg and colleagues 16 reported a remission-associated decrease in the activity of this region during antidepressant treatment, Nobler and colleagues 86 obtained analogous results after ECT administration, and Mayberg and colleagues 28 showed that CBF decreased in the sgACC and other ventromedial PFC regions during improvement associated with deep brain stimulation of the sgACC. Also consistent with these data, several studies have shown that in MDD the depression severity correlates positively with blood flow or metabolism in the sgACC 79 compatible with evidence that blood flow increases in the sgACC in healthy humans during experimentally induced sadness. 70, 71 Finally, the abnormal elevation of sgACC metabolism that Mah and colleagues 43 and others 39 observed in depressed bipolar disorder subjects were limited to cases who were medicated chronically with lithium or divalproex. Chronic lithium treatment resulted in increased gray matter volume in the sgACC (Figure 3) , 3 consistent with evidence from preclinical studies 87 indicating that lithium and divalproex exert neurotrophic and neuroprotective effects in the frontal cortex of experimental animals. If the increase in sgACC tissue is sufficient to reduce the partial volume averaging effect in PET images, then metabolic activity would be imaged as being elevated in such depressed subjects versus controls (Table 5) . Longitudinal imaging studies acquired both pre-and post-mood stabilizer therapy are needed to characterize relationships between volume and metabolism.
NEUROPATHOLOGICAL MEASURES: CORRELATIONS WITH RODENT MODELS OF REPEATED STRESS
Although it remains unclear whether they reflect a neurodevelopmental abnormality or an acquired effect of recurrent illness, it is noteworthy that in regions that appear homologous to areas where gray matter reductions are evident in depressed humans (ie, medial PFC, hippocampus), repeated stress results in dendritic atrophy and reductions in glial cells in rodents. [88] [89] [90] [91] [92] Dendritic atrophy putatively would be reflected by a decrease the volume of the neuropil. These data suggest that impaired emotion regulation may contribute to the volumetric abnormalities found in these structures in MDD, by permitting stress responses that are exaggerated in magnitude or duration. 92 Such changes could, in turn, exacerbate the emotion dysregulation associated with bipolar disorder, as in rodents dendritic atrophy arising in the medial PFC during repeated stress resulted in impaired modulation (ie, extinction) of behavioral responses to fear-conditioned stimuli. 91 Notably, when rats were subjected to repeated stress, the dendritic atrophy could be reversed by lithium administration, 90 resembling the effects of lithium on the gray matter reductions in bipolar disorder (Figure 3) .
The stress-induced dendritic remodeling process depends upon interactions between the increased N-methyl-D-aspartate receptor stimulation and glucocorticoid secretion associated with repeated stress. 92 The depressive subtypes (eg, bipolar disorder, familial pure depressive disease) who show regional reductions in gray matter volume also show evidence of increased cortisol secretion during stress 94 and glutamatergic transmission (eg, elevated glucose metabolism predominantly reflects corresponding increases in glutamatergic transmission. 95 Notably, impaired sgACC function in mood disorders may conceivably contribute to cortisol hypersecretion in depression. 96 Diorio and colleagues 97 showed that glucocorticoid receptors expressed in the ventral ACC play a major role in the negative feedback effect of glucocor- 
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Frontal polar cortex (BA 10) Another potential predisposition for undergoing excessive remodeling in the sgACC may be the "short" allele of the serotonin transporter promoter length polymorphism. This polymorphism was associated with reduced gray matter in the sgACC, reduced functional connectivity between the amygdala and the sgACC, and higher temperamental anxiety in otherwise healthy s-carriers. 97 Conceivably, this effect may prove maladaptive under severe stress, potentially underlying the increased risk the s-allele confers for developing depression within the context of stress.
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RELATIONSHIP BETWEEN STRUCTURAL ABNORMALITIES IN THE SUBGENUAL ANTERIOR CINGULATE CORTEX AND OTHER REGIONS
The sgACC shares substantial, predominantly ipsilateral anatomical connections with the amygdala and subiculum, and it is possible that the left-lateralized volumetric reductions in these structures are related. In the amygdala, left-lateralized reductions in glia have been demonstrated in MDD, 68, 69 although the literature disagrees about the direction and existence of volumetric changes in mood disorders. In the hippocampus, MDD subjects showed greater decrements in volume following fixation (implying a deficit in the neuropil), 99 while, more specifically, in the hippocampal subiculum/ventral CA1 region, bipolar disorder subjects had reductions in synapses and synaptic proteins 100, 101 and left-lateralized reductions in gray matter 102 compared with controls. The sgACC also projects to the ventromedial striatum and the accumbens area, 4 which were reported to be abnormally small in a postmortem volumetric study of mood disorders, 103 and to the periventricular and mediodorsal nuclei of the thalamus that line the third ventricle wall. Although, third ventricle enlargement is consistently found in bipolar disorder, the specific tissue where volume loss resulted in ex vaccuo changes in third ventricle size has remained unclear. 7, 13 Nevertheless, taken together, these data suggest that mood disorders are associated with a neuropathological process affecting circuits that involve the sgACC together with anatomically related parts of the orbitomedial PFC, amygdala, hippocampus, striatum, and thalamus.
POTENTIAL CLINICAL CORRELATES OF SUBGENUAL PREFRONTAL CORTEX DYSFUNCTION
In monkeys and other experimental animals, the putatively homologous cortex to the sgACC shares extensive anatomical connections with the amygdala; subiculum; hypothalamus; accumbens; ventral tegmental area (VTA); substantia nigra; raphe; locus ceruleus; periaqueductal gray and brainstem autonomic nuclei; and other areas of the orbitomedial PFC. 4, 76 These structures are implicated in the modulation of emotional behavior, raising the possibility that abnormal synaptic interactions between these areas and the sgACC may contribute to disturbances in emotional processing or regulation. 3 Rats with bilateral lesions of the ACC and dorsal prelimbic cortex show exaggerated freezing behavior and heart rate increases during exposure to fear-conditioned sensory and/or contextual stimuli. 104, 105 In contrast, bilateral lesions involving the infralimbic and the ventral prelimbic cortices result in reduced heart rate responses to fear-conditioned stimuli. 105 Sullivan and Gratton 106 more specifically showed that rats with lesions involving the left infralimbic, prelimbic, and anterior cingulate cortices demonstrated heightened sympathetic autonomic arousal and exaggerated CORT responses to restraint stress relative both to control animals and to animals with right-sided lesions of the same areas. In contrast, right-lesioned animals showed attenuation of the CORT rise and the autonomically mediated gastric stress pathology associated with restraint stress. From these data, Sullivan and Grattan 106 concluded that left ventromedial PFC lesions disinhibit the function of the right ventromedial PFC, which mediates the heightened sympathetic autonomic, affective, and hypothalamic-pituitary-adrenal axis arousal seen in the left-lesioned animals. In mood disorders, an altered balance between left and right sgACC function conceivably may contribute to the heightened affective, neuroendocrine, and sympathetic autonomic arousal seen in depression.
For example, depression has been associated with a reduction in the parasympathetic-to-sympathetic tone that is hypothesized to contribute to the elevated risks for developing ventricular tachycardia, myocardial infarction, and sudden death in depressed patients with cardiovascular disease. 107 The extensive interconnections between the posterior sgACC (BA 25) and the nucleus tractus solitarious of the vagus nerve that mediate parasympathetic function led to this region initially being termed "visceromotor cortex. " 105 The anterior sgACC and pgACC share more prominent projections with the PAG columns that mediate sympathetic autonomic expression. 108 Lesions of the ventromedial PFC also alter parasympathetic autonomic function in rats in a manner that shows an intriguing parallel with autonomic abnormalities reported in humans with MDD. 105 Together, these data suggest the hypothesis that dysfunction of the sgACC results in understimulation of parasympathetic tone in mood disorders.
Humans with lesions that include the sgACC demonstrate abnormal autonomic responses to emotional experiences, inability to experience emotion related to concepts that ordinarily evoke emotion, and inability to use information regarding the likelihood of punishment versus reward in guiding social behavior. 109 Based partly upon these observations 110 proposed that the ability to evaluate the consequences of social behavior depends upon visceral feedback mediated through interactions between the ventromedial PFC, hypothalamic autonomic centers, and brainstem monoaminergic neurotransmitter systems. Although the ventromedial PFC lesions under consideration affected such a large region that it was not possible to draw specific conclusions regarding the sgACC from such cases, these observations, combined with the known connectivity of the sgACC, suggest the hypothesis that pathological modulation of visceral feedback may underlie the oversensitivity to failure and pathological guilt in depression and the insensitivity to the negative outcome of pleasurable or violent behavior in mania.
Finally, the role of the ventral ACC in modulating the electrophysiological responses of VTA dopamine neurons suggests this cortex may also participate in evaluating the salience of rewards. Of the PFC areas that receive dopaminergic inputs, BA 24 of the ACC receives the most dense dopamine innervation (principally from the VTA), and in rats, electrical or glutamatergic stimulation of ventral ACC elicits burst-firing patterns of dopaminergic cells in the VTA and dopamine release in the nucleus accumbens. 76 The phasic, burst firing of dopamine neurons and accompanying rise in dopamine release normally occur in response to primary rewards and reward-predicting stimuli. 111 The findings that glucose metabolism in the sgACC is abnormally decreased in the depressed but increased in the manic phases of bipolar disorder 1 suggests the hypothesis that, in depression, reduced sgACC activity is associated with diminished stimulation of mesolimbic dopamine release, resulting in the absence of behavioral incentive, apathy, and anhedonia, whereas in mania increased sgACC activity results in excessive stimulation of mesolimbic dopamine release, manifested by exaggerated hedonic responses and elevated motivational drive.
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CONCLUSION: ROLE IN NEURAL CIRCUITS AFFECTED BY MOOD DISORDERS
Neuroimaging, neuropathological, and lesion analysis data implicate an extended anatomical network formed by the neural projections of the sgACC and other areas of the orbitomedial PFC with the amygdala; hippocampus; superior and medial temporal gyri; ventral striatum; mid-and posterior cingulate cortex; thalamus; hypothalamus; periaqueductal gray; and habenula, 4 in the regulation of the evaluative, expressive, and experiential aspects of emotion. 55 Impaired function within this network could conceivably dysregulate emotional expression and experience, conceivably giving rise to the clinical signs and symptoms of depression or mania.
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